Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Immaculada Margarit

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
Bioconjugate Chemistry|September 11, 2015
Correction to Exploring the Effect of Conjugation Site and Chemistry on the Immunogenicity of an anti-Group B Streptococcus Glycoconjugate Vaccine Based on GBS67 Pilus Protein and Type V PolysaccharideAlberto Nilo, Irene Passalacqua, Monica Fabbrini, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 15, 2020
Structure-Guided Design of a Group B Streptococcus Type III Synthetic Glycan-Conjugate VaccineDavide Oldrini, Linda Del Bino, Ana Arda, et al.
The Journal of Infectious Diseases|October 22, 2008
Sequence variation in group A Streptococcus pili and association of pilus backbone types with lancefield T serotypesFabiana Falugi, Chiara Zingaretti, Vittoria Pinto, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 12, 2020
Structure-Guided Design of a Group B Streptococcus Type III Synthetic Glycan-Conjugate VaccineDavide Oldrini, Linda Del Bino, Ana Arda, et al.
Molecular Microbiology|July 11, 2006
Identification of novel genomic islands coding for antigenic pilus-like structures in Streptococcus agalactiaeRoberto Rosini, Cira Daniela Rinaudo, Marco Soriani, et al.
Bioconjugate Chemistry|August 1, 2015
Exploring the Effect of Conjugation Site and Chemistry on the Immunogenicity of an anti-Group B Streptococcus Glycoconjugate Vaccine Based on GBS67 Pilus Protein and Type V PolysaccharideAlberto Nilo, Irene Passalacqua, Monica Fabbrini, et al.
ACS Chemical Biology|April 24, 2015
Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed ConjugationAlberto Nilo, Laura Morelli, Irene Passalacqua, et al.
Plos One|May 7, 2015
Genomic analysis reveals the molecular basis for capsule loss in the group B Streptococcus populationRoberto Rosini, Edmondo Campisi, Matteo De Chiara, et al.
Infection and Immunity|April 30, 2014
SpyAD, a moonlighting protein of group A Streptococcus contributing to bacterial division and host cell adhesionMarilena Gallotta, Giovanni Gancitano, Giampiero Pietrocola, et al.
Molecular & Cellular Proteomics : MCP|April 30, 2009
Surfome analysis as a fast track to vaccine discovery: identification of a novel protective antigen for Group B Streptococcus hypervirulent strain COH1Francesco Doro, Sabrina Liberatori, Manuel J Rodríguez-Ortega, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Bioconjugate Chemistry|September 11, 2015
Correction to Exploring the Effect of Conjugation Site and Chemistry on the Immunogenicity of an anti-Group B Streptococcus Glycoconjugate Vaccine Based on GBS67 Pilus Protein and Type V PolysaccharideAlberto Nilo, Irene Passalacqua, Monica Fabbrini, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 15, 2020
Structure-Guided Design of a Group B Streptococcus Type III Synthetic Glycan-Conjugate VaccineDavide Oldrini, Linda Del Bino, Ana Arda, et al.
The Journal of Infectious Diseases|October 22, 2008
Sequence variation in group A Streptococcus pili and association of pilus backbone types with lancefield T serotypesFabiana Falugi, Chiara Zingaretti, Vittoria Pinto, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 12, 2020
Structure-Guided Design of a Group B Streptococcus Type III Synthetic Glycan-Conjugate VaccineDavide Oldrini, Linda Del Bino, Ana Arda, et al.
Molecular Microbiology|July 11, 2006
Identification of novel genomic islands coding for antigenic pilus-like structures in Streptococcus agalactiaeRoberto Rosini, Cira Daniela Rinaudo, Marco Soriani, et al.
Bioconjugate Chemistry|August 1, 2015
Exploring the Effect of Conjugation Site and Chemistry on the Immunogenicity of an anti-Group B Streptococcus Glycoconjugate Vaccine Based on GBS67 Pilus Protein and Type V PolysaccharideAlberto Nilo, Irene Passalacqua, Monica Fabbrini, et al.
ACS Chemical Biology|April 24, 2015
Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed ConjugationAlberto Nilo, Laura Morelli, Irene Passalacqua, et al.
Plos One|May 7, 2015
Genomic analysis reveals the molecular basis for capsule loss in the group B Streptococcus populationRoberto Rosini, Edmondo Campisi, Matteo De Chiara, et al.
Infection and Immunity|April 30, 2014
SpyAD, a moonlighting protein of group A Streptococcus contributing to bacterial division and host cell adhesionMarilena Gallotta, Giovanni Gancitano, Giampiero Pietrocola, et al.
Molecular & Cellular Proteomics : MCP|April 30, 2009
Surfome analysis as a fast track to vaccine discovery: identification of a novel protective antigen for Group B Streptococcus hypervirulent strain COH1Francesco Doro, Sabrina Liberatori, Manuel J Rodríguez-Ortega, et al.
Pageof 9